| Patient Safety |
1 |
1 |
| Pregnancy |
0 |
1 |
| Acne |
0 |
0.81 |
| COVID-19 |
0 |
0.61 |
| Isotretinoin |
0 |
0.57 |
| Rosacea |
0 |
0.53 |
| Pediatric Dermatology |
0 |
0.51 |
| Child |
0 |
0.36 |
| Contraception |
0 |
0.36 |
| California |
0 |
0.29 |
| Hospital |
0 |
0.29 |
| Revenue and Practice Management |
0 |
0.29 |
| Risk Management |
0 |
0.21 |
| Sterilization, Birth Control |
0 |
0.2 |
| Adolescent Medicine |
0 |
0.19 |
| Skin and Soft Tissue Infection |
0 |
0.18 |
| Birth |
0 |
0.14 |
| Emergency Contraception |
0 |
0.14 |
| Insurance |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.12 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Telehealth and Telemedicine |
0 |
0.09 |
| Blood |
0 |
0.07 |
| Drug and Treatment Safety |
0 |
0.07 |
| Echocardiography |
0 |
0.07 |
| Generics |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Health Care Inequities |
0 |
0.07 |
| Interprofessional Continuing Education |
0 |
0.07 |
| Match |
0 |
0.07 |
| Medical Records |
0 |
0.07 |
| Ophthalmic |
0 |
0.07 |
| Patient Counseling |
0 |
0.07 |
| Polycystic Ovary Syndrome |
0 |
0.07 |
| Shared Decision-Making |
0 |
0.07 |
| Texas |
0 |
0.07 |
| Washington |
0 |
0.07 |